Posts Tagged: Fracture reduction

Vitamin D, Calcium, and Common Sense

Vitamin D and Calcium Supplements

Confused about calcium and vitamin D? Who isn’t? The recent media coverage on the topic of calcium and vitamin D has created a tremendous amount of confusion among not only you, but your health care providers, too. Unfortunately, this news coverage may be counterproductive to promoting adequate calcium and vitamin D intake for bone health.… Read more

Amgen’s Osteoporosis Drug PROLIA™ Approved by the FDA


On the heels of the European Union’s approval, the FDA announced today approval of Amgen’s osteoporosis drug Prolia™ (denosumab) for treatment of postmenopausal women with osteoporosis. We were expecting news later in the summer, so this early announcement was a surprise. Prolia™ is given in your doctor’s office as a shot under the skin twice… Read more

Unique New Drug Approved for Treatment of Osteoporosis in EU

EU Flag

Prolia™ (denosumab), a medicine for treatment of osteoporosis under review by the FDA, received approval today (May 28, 2010) for marketing in the European Union. For Amgen, the maker of Prolia™, this was the drug’s first approval for use. The approval was 2-fold: 1- for treatment of osteoporosis in postmenopausal women at increased risk of fractures… Read more